1.96 USD
↗ 0.03 (1.30%)LIVE (AS OF 03:22 PM EDT)
INmune Bio Inc. Common stock
INMBNASDAQ • USD
Market: OPEN
INmune Bio Inc. Common stock (INMB) trades at $1.96 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 2, 2026.
Open?$1.90
High?$1.96
Low?$1.88
Prev. Close?$1.93
Volume?198.9K
Avg. Volume?344.2K
VWAP?$1.92
Rel. Volume?0.58x
Bid / Ask
Bid?$1.93 × 700
Ask?$1.94 × 500
Spread?$0.01
Midpoint?$1.94
Valuation & Ratios
Market Cap?53.6M
Shares Out?27.8M
Float?23.6M
Float %?88.8%
P/E Ratio?N/A
P/B Ratio?2.63
EPS?-$0.66
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Employees
21
Market Cap
53.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2019-02-04
Address
225 NE MIZNER BLVD, SUITE 640
BOCA RATON, FL 33432
Phone: (858) 964-3720
BOCA RATON, FL 33432
Phone: (858) 964-3720
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.97Distress
Confidence?49%Low
Short InterestHigh
Short % of Float?9.53%Elevated
Short Interest?2.3M
Days to Cover?7.8
Free Float23.6M
Avg Daily Volume289.2K
Settlement Date2026-09-15
Financial Health
Current Ratio?4.04Strong
Quick Ratio?4.04Strong
Cash Ratio?3.13Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.63CHEAP▾
Peers100
S&P62
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-90.4%WEAK▾
S&P3
ROA?-68.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15727000
Enterprise Value?$35.2M
Fundamentals ratios updated end of day